News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Hospira, Inc. (HSP) Recalls Pain Injectable on Overdose Risk


8/17/2012 7:37:28 AM

The U.S. Food and Drug Administration said Hospira Inc is voluntarily recalling one lot of its hydromorphone pain relieving injection as it may contain more than the intended fill volume, posing a risk of drug overdose. Overdose of opioid pain medications such as hydromorphone may lead to life-threatening consequences, including slowed breathing, low blood pressure and reduced heart rate, the FDA said. Hospira began the recall on Thursday after a complaint that one Carpuject - the drug delivery system - contained more than the intended 1ml labeled fill volume.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES